Sight Sciences 8-K: Executive Comp/Officer Changes Reported
Ticker: SGHT · Form: 8-K · Filed: Feb 2, 2024 · CIK: 1531177
| Field | Detail |
|---|---|
| Company | Sight Sciences, Inc. (SGHT) |
| Form Type | 8-K |
| Filed Date | Feb 2, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: executive-changes, compensation, corporate-governance
TL;DR
**Sight Sciences filed an 8-K about executive changes, watch for details on leadership and pay.**
AI Summary
Sight Sciences, Inc. filed an 8-K on February 2, 2024, reporting an event that occurred on January 30, 2024, related to changes in its executive compensation or officer appointments. This filing, under Item 5.02, signals potential shifts in leadership or how key executives are compensated. For investors, this matters because changes in executive compensation or leadership can impact company strategy, financial performance, and ultimately, stock value.
Why It Matters
Changes in executive compensation or officer roles can signal strategic shifts or leadership stability, directly influencing investor confidence and future company direction.
Risk Assessment
Risk Level: medium — The filing indicates a change in officers or their compensation, which could be positive or negative depending on the specifics, thus presenting a medium risk.
Analyst Insight
A smart investor would monitor for subsequent filings or press releases from Sight Sciences, Inc. that provide specific details about the executive changes or compensation arrangements, as these specifics will determine the actual impact on the company.
Key Players & Entities
- Sight Sciences, Inc. (company) — the registrant filing the 8-K
- January 30, 2024 (date) — date of the earliest event reported
- February 2, 2024 (date) — date the 8-K was filed
- SGHT (company) — trading symbol for Sight Sciences, Inc.
- Nasdaq Global Select Market (company) — exchange where Sight Sciences, Inc. common stock is registered
Forward-Looking Statements
- Further details regarding the specific executive changes or compensation arrangements will be disclosed in subsequent filings or company announcements. (Sight Sciences, Inc.) — high confidence, target: Q1 2024
FAQ
What is the specific item number under which Sight Sciences, Inc. filed this 8-K?
Sight Sciences, Inc. filed this 8-K under Item 5.02, which covers 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers'.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on January 30, 2024.
What is the trading symbol for Sight Sciences, Inc. and on which exchange is it registered?
The trading symbol for Sight Sciences, Inc. is SGHT, and its common stock is registered on The Nasdaq Global Select Market.
What is the business address of Sight Sciences, Inc. as stated in the filing?
The business address of Sight Sciences, Inc. is 4040 Campbell Avenue, Suite 100, Menlo Park, California, 94025.
What is the purpose of an 8-K filing under Item 5.02?
An 8-K filing under Item 5.02 is used to report the departure or election of directors, the appointment of certain officers, or changes in the compensatory arrangements of certain officers.
Filing Stats: 684 words · 3 min read · ~2 pages · Grade level 14.3 · Accepted 2024-02-02 16:02:01
Key Financial Figures
- $0.001 — nge on which registered Common Stock, $0.001 par value per share SGHT The Nasdaq
Filing Documents
- d674955d8k.htm (8-K) — 32KB
- 0001193125-24-022830.txt ( ) — 156KB
- sght-20240130.xsd (EX-101.SCH) — 3KB
- sght-20240130_lab.xml (EX-101.LAB) — 18KB
- sght-20240130_pre.xml (EX-101.PRE) — 11KB
- d674955d8k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Sight Sciences, Inc. Date: February 2, 2024 By: /s/ Alison Bauerlein Chief Financial Officer